Cirrhosis and liver cancer are among the leading causes of death in Vietnam, with the incidence rate among the highest in the Asia-Pacific region. Early diagnosis plays a key role in treatment and improving the quality of life for patients. In an effort to jointly address this challenge, M2BPGi - a blood biomarker test, promises to bring a breakthrough in the early diagnosis of liver cancer and cirrhosis.
Tag Archives: Y khoa Việt Nam
On the morning of January 4, 2025, at the large hall of Bach Mai Hospital (Hanoi), the founding congress of the Vietnam Interventional Gastrointestinal Endoscopy Society (VIGES) took place successfully, opening a new chapter for the digestive medicine industry in Vietnam.